Spatiotemporal Mapping IDs Four Stages of Inflammatory Bowel Disease Evolution
By Lori Solomon HealthDay Reporter
.jpeg?width=1200)
TUESDAY, May 6, 2025 -- Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD), according to a study published online April 30 in Nature.
Lindsay Hracs, Ph.D., from the University of Calgary in Alberta, Canada, and colleagues identified 522 population-based studies encompassing 82 global regions and spanning more than a century (1920 to 2024) to show spatiotemporal transitions across IBD stages 1 to 3 and model stage 4 progression using machine learning.
The researchers report that developing regions in Africa, Asia, and Latin America are likely in stage 1 (emergence) and transitioning to stage 2 (acceleration in incidence) following economic growth, industrialization, urbanization, and changes in lifestyle and diet. Countries in North America, Europe, and Oceania are currently in stage 3 (compounding prevalence), with a growing number of people living with IBD, including an increasing proportion of seniors. The prevalence of IBD will continue to rise as people live longer with the disease. However, the rate of growth is expected to slow, with an aging population, and will move toward stage 4 (prevalence equilibrium), where new diagnoses are gradually balanced by age-related deaths.
"The findings enable health authorities to prepare for IBD's growing burden and tailor interventions -- whether clinical, policy driven, or preventive," principal author Gilaad G. Kaplan, M.D., also from the University of Calgary, said in a statement.
Several authors disclosed financial ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
FDA Offers Speedier Approvals to Drug Companies Aligning With 'National Priorities'
WEDNESDAY, June 18, 2025 -- On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will...
Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
WEDNESDAY, June 18, 2025 -- Waist-to-height ratio (WHtR) outperforms body mass index (BMI) in detecting the risk for liver disease, according to a study published in the July...
Virtual Reality Training Module May Aid Infection Control Efforts
TUESDAY, June 17, 2025 -- Users report positive experiences and engagement with a virtual reality tool that trains clinicians on core concepts in infection control, including...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.